These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 28523511

  • 1. ["Therapy-resistant polymyositis" - is the diagnosis correct?].
    Ceccon G, Lehmann HC, Neuen-Jacob E, Meng G, Fink GR, Wunderlich G.
    Z Rheumatol; 2017 Sep; 76(7):640-643. PubMed ID: 28523511
    [Abstract] [Full Text] [Related]

  • 2. Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.
    Contreras-Cubas C, Barajas-Olmos F, Frayre-Martínez MI, Siordia-Reyes G, Guízar-Sánchez CC, García-Ortiz H, Orozco L, Baca V.
    BMC Med Genomics; 2022 Jun 20; 15(1):139. PubMed ID: 35725460
    [Abstract] [Full Text] [Related]

  • 3. Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage: Case report and literature review.
    Xu C, Chen J, Zhang Y, Li J.
    Medicine (Baltimore); 2018 May 20; 97(21):e10539. PubMed ID: 29794729
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K, Bassez G, Krahn M, Bernard R, Laforêt P, Labelle V, Urtizberea JA, Figarella-Branger D, Romero N, Attarian S, Leturcq F, Pouget J, Lévy N, Eymard B.
    Arch Neurol; 2007 Aug 20; 64(8):1176-82. PubMed ID: 17698709
    [Abstract] [Full Text] [Related]

  • 5. [Dysferlinopathy masquerading as a refractory polymyositis].
    Loureiro Amigo J, Gallardo E, Gallano P, Grau-Junyent JM.
    Med Clin (Barc); 2015 Nov 06; 145(9):414-5. PubMed ID: 25662721
    [No Abstract] [Full Text] [Related]

  • 6. Dysferlin deficiency treated like refractory polymyositis.
    Vinit J, Samson M, Gaultier JB, Laquerriere A, Ollagnon E, Petiot P, Marie I, Levesque H, Rousset H.
    Clin Rheumatol; 2010 Jan 06; 29(1):103-6. PubMed ID: 19730931
    [Abstract] [Full Text] [Related]

  • 7. [Progressive muscular weakness of lower limbs revealing a limb girdle muscular dystrophy].
    Saintmard G, Brands G, Debray FG, Lognard M.
    Rev Med Liege; 2017 Jul 06; 72(7-8):373-376. PubMed ID: 28795552
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis.
    Angelini C, Grisold W, Nigro V.
    Acta Myol; 2011 Dec 06; 30(3):185-7. PubMed ID: 22616201
    [Abstract] [Full Text] [Related]

  • 9. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z, Hu J, Sakiyama Y, Okamoto Y, Higuchi I, Li N, Shen H, Takashima H.
    Clin Neurol Neurosurg; 2013 Aug 06; 115(8):1234-7. PubMed ID: 23254335
    [Abstract] [Full Text] [Related]

  • 10. Myositis or dystrophy? Traps and pitfalls.
    Benveniste O, Romero NB.
    Presse Med; 2011 Apr 06; 40(4 Pt 2):e249-55. PubMed ID: 21377315
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneous characteristics of Korean patients with dysferlinopathy.
    Park HJ, Hong JM, Suh GI, Shin HY, Kim SM, Sunwoo IN, Suh BC, Choi YC.
    J Korean Med Sci; 2012 Apr 06; 27(4):423-9. PubMed ID: 22468107
    [Abstract] [Full Text] [Related]

  • 12. Late onset dysferlinopathy mimicking treatment resistant polymyositis.
    Griger Z, Nagy-Vincze M, Bodoki L, Gherardi RK, Dankó K, Hortobágyi T.
    Joint Bone Spine; 2016 May 06; 83(3):355-6. PubMed ID: 26471412
    [No Abstract] [Full Text] [Related]

  • 13. Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy.
    Patel NJ, Van Dyke KW, Espinoza LR.
    Am J Med Sci; 2017 May 06; 353(5):484-491. PubMed ID: 28502335
    [Abstract] [Full Text] [Related]

  • 14. Compound heterozygous DYSF variants causing limb-girdle muscular dystrophy type 2B in a Chinese family.
    Li L, Jing Z, Cheng L, Liu W, Wang H, Xu Y, Zheng X, Yu X, Liu S.
    J Gene Med; 2020 Nov 06; 22(11):e3272. PubMed ID: 32889728
    [Abstract] [Full Text] [Related]

  • 15. Limb-girdle muscular dystrophy type 2B: An unusual cause of proximal muscular weakness in Saudi Arabia.
    Algahtani H, Shirah B, Alassiri AH, Habib BA, Almuhanna R, Ahamed MF.
    J Back Musculoskelet Rehabil; 2018 Nov 06; 31(5):999-1004. PubMed ID: 29966189
    [Abstract] [Full Text] [Related]

  • 16. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
    Nalini A, Gayathri N.
    Neurol India; 2008 Nov 06; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
    [Abstract] [Full Text] [Related]

  • 17. Late onset in dysferlinopathy widens the clinical spectrum.
    Klinge L, Dean AF, Kress W, Dixon P, Charlton R, Müller JS, Anderson LV, Straub V, Barresi R, Lochmüller H, Bushby K.
    Neuromuscul Disord; 2008 Apr 06; 18(4):288-90. PubMed ID: 18396043
    [Abstract] [Full Text] [Related]

  • 18. New aspects on patients affected by dysferlin deficient muscular dystrophy.
    Klinge L, Aboumousa A, Eagle M, Hudson J, Sarkozy A, Vita G, Charlton R, Roberts M, Straub V, Barresi R, Lochmüller H, Bushby K.
    J Neurol Neurosurg Psychiatry; 2010 Sep 06; 81(9):946-53. PubMed ID: 19528035
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of dysferlinopathy masked by a superimposed hypothyroid myopathy.
    Benn KW, Bhalala OG, Day TJ, French CR.
    BMJ Case Rep; 2024 Aug 16; 17(8):. PubMed ID: 39153757
    [Abstract] [Full Text] [Related]

  • 20. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
    Szymanska S, Rokicki D, Karkucinska-Wieckowska A, Szymanska-Debinska T, Ciara E, Ploski R, Grajkowska W, Pronicki M.
    Folia Neuropathol; 2014 Aug 16; 52(4):452-6. PubMed ID: 25574751
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.